North Dakota is being sued by a second pharmaceutical company over legislation passed during the 2025 session that expands access to drugs discounted by the federal 340B program. Drug maker ...

A new law regulating a federal drug discount program in Rhode Island went into effect on Wednesday, Oct. 1, after a District Court judge denied a preliminary injunction requested by a pharmaceutical ...

If HHS’ 340B rebate model pilot proceeds as planned, more than 2,700 U.S. hospitals will collectively be saddled with approximately $400 million in operational costs and 11.2 million labor burden ...

The number of 340B providers has grown from about 10,000 to 66,000 in the past 15 years, while the number of contract pharmacies increased from 1,300 to 253,000 over the same time. The dramatic growth ...

Improving access to care and managing healthcare costs are constant priorities for physicians. For this reason, I’m glad to see Senator Tammy Baldwin’s focus on a bipartisan approach to reforming the ...

Large nonprofit hospitals are distorting the healthcare system by engaging in pricing that increases costs on taxpayers. Our nation needs to move toward a market-based, free-market system that has ...

A U.S. federal judge has rejected challenges by two pharmaceutical manufacturers seeking to block a Maine law that regulates the use of contract pharmacies under the federal 340B drug discount program ...

The White House has proposed good and bad ideas to reduce drug costs. Among the better ones is a reform of the obscure 340B drug program, which enriches large hospitals at the expense of patients. Cue ...

The 340B drug discount program incentivizes hospitals to purchase outpatient clinics and prescribe more and higher-cost drugs — behaviors that tend to increase costs for the federal government and ...

The 340B Drug Pricing Program allows certain medical facilities to buy drugs at a discount to support care for low-income patients. Rhode Island's new law, Chapter 288, prevents drug makers from ...

A bipartisan group of 163 lawmakers is urging the Department of Health and Human Services (HHS) to cancel an upcoming pilot of after-the-fact rebates for drugs hospitals purchase through the 340B Drug ...

When we talk about the U.S. healthcare crisis, the conversations often turn to buzzwords: skyrocketing premiums, pharmaceutical greed, hospital consolidations. However, the real emergency isn’t just ...